Hualan

301207.SZ

Tags: CN Healthcare Biotechnology

Hualan Biological Bacterin Inc. Price (301207.SZ)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

602,429,841

(0.4025)%

Market Cap of Hualan (301207.SZ)

Market cap:

As of , 301207.SZ has a market cap of . This makes 301207.SZ the 1263th most valuable company in the CN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Hualan Biological Bacterin Inc. engages in the research, development, production, and sale of vaccines in China. It offers It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A and C meningococcal polysaccharide vaccines, as well as genetic engineering vaccines for human use. The company was founded in 2005 and is based in Xinxiang, China. Hualan Biological Bacterin Inc. was formerly a s... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $15.42-25.3
Market Cap 10.74B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Ms. Wenjue An
IPO Date: February, 18, 2022
Country: CN
Currency: CNY
Headquaters: No Data
Employees: 770

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: